BTV-Business Television - biOasis Technologies Enters into License Agreement with a Major Pharmaceutical Company

Vancouver, British Columbia--(Newsfile Corp. - April 4, 2014) - On BNN and FOX Business News Network on Sun Apr 6, 2014 - on National TV, BTV-Business Television highlights biOasis Technologies (TSXV: BTI) (OTCQX: BIOAF). This company has entered into a license agreement with a major pharmaceutical company.

If you cannot view the video above, please visit:
http://www.b-tv.com/features/watch-now.html?id=588

ABOUT BIOASIS TECHNOLOGIES INC (TSXV: BTI) (OTCQX: BIOAF)

biOasis Technologies Inc. is a publically traded biopharmaceutical company focused on developing and commercializing proprietary pharmaceutical products and diagnostic technologies for central nervous system ("CNS") diseases and disorders. Of particular interest is the creation of therapeutic options presented by the properties of the blood-brain barrier ("BBB").

For more information visit: http://www.bioasis.ca/.

ABOUT BTV:

BTV, a half-hour weekly business news program, profiles emerging companies across Canada and the USA to bring investors information for their portfolio. With Host Taylor Thoen, BTV features companies at their location, interviews the company's key executives and features their products and services.

For more information visit: www.b-tv.com.

BTV Broadcast Times:

CANADA:
BNN - Sunday, Apr 6 @ 9:30am & 8:00pm EST
Bell Express Vu - Sunday, Apr 6 @ 9:30am & 8:00pm EST

U.S. National:
Fox Business News - Sunday, Apr 6 @ 5:30pm EST
America One - Saturday, Apr 5 @ 10am EST
Biz Television Network - Thurs. Apr 10 @ 10:00pm & 1:00am EST and Sun Apr 13 @ 12:30pm, 9:00pm & 12:00am EST

Contact: (604) 664-7401x 3 info@b-tv.com